LOP628

News alerts, weekly reports and conference planners

Company:

Novartis

Drug class:

Microtubule inhibitor, c-KIT-targeted antibody-drug conjugate

KIT positive	Gastrointestinal Stromal Tumor	KIT positive	Gastrointestinal Stromal Tumor	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D
KIT positive	Acute Myelogenous Leukemia	KIT positive	Acute Myelogenous Leukemia	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D
KIT positive	Small Cell Lung Cancer	KIT positive	Small Cell Lung Cancer	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D

Associations
(3)